Ketamine effects on eye movements

Neuropsychopharmacology

Volumn 23, Issue 6, 2000, Pages 645-653

  Weiler, Martin A ^a,b   Thaker, Gunvant K ^a   Lahti, Adrienne C ^a   Tamminga, Carol A ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Ketamine; NMDA; Schizophrenia; Smooth pursuit eye movements

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EYE MOVEMENT; FAMILIAL DISEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOOTH PURSUIT EYE MOVEMENT; VELOCITY; VOLUNTEER;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE MOVEMENTS; FEMALE; HUMANS; KETAMINE; MALE; NEUROPSYCHOLOGICAL TESTS; OCULAR MOTILITY DISORDERS; PSYCHOMOTOR PERFORMANCE; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 0033784718     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00156-1     Document Type: Article

References (44)

1. A unitary model of schizophrenia
2. Cognitive dysmetria as an integrative theory of schizophrenia; A dysfunction in cortical-cerebellar circuitry?
3. Neuronal correlates of inferred motion in primate posterior parietal cortex
4. Pursuit of intermittently illuminated moving targets in the human
5. Prediction in the oculomotor system; Smooth pursuit during transient disappearance of a visual target
6. Pathways for motion analysis; Cortical connections of the medial superior temporal and fundus of the superior temporal visual areas in the macaque
7. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
8. Psychosis proneness
9. Smooth pursuit in schizophrenia; Abnormalities in open- and closed- loop responses
10. An experimental study of the ocular reactions of the insane from photographic records
11. Responses of neurons in the partial and temporal visual pathways during a motion task
12. A model of smooth pursuit performance illustrates the relationship between gain, catch-up saccade rate and catch-up saccade amplitude in normal controls and patients with schizophrenia
13. Ketamine; Acquisition and retention of classically conditioned responses during treatment with large doses
14. Eye tracking patterns in schizophrenia
15. Timing functions of the cerebellum
16. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia
17. Recent advances in the phencyclidine model of schizophrenia
18. Localization of a cerebellar timing process using PET
19. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans; Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
20. Ketamine activates psychosis and alters limbic blood flow in schizophrenia
21. Effects of ketamine on behavior and rCBF in schizophrenic and normal individuals
22. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
23. Absence of ketamine effects on memory and other cognitive functions in schizophrenic patients
24. Eye tracking dysfunction and schizophrenia; A critical perspective
25. Study of a new schizophrenomimetic drug; Serenyl
26. NMDA receptor function and human cognition; The effects of ketamine in healthy volunteers
27. Cerebellum and schizophrenia; A selective review
28. Activation of glutamatergic neurotransmission by ketamine; A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
29. Deficits in smooth pursuit initiation in patients with degenerative cerebellar lesions
30. Molecular diversity of glutamate receptors and implications for brain function
31. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis
32. Relation of cortical areas MT and MST to pursuit eye movements. II. Differentiation of retinal from extraretinal inputs
33. Regional variations in the pharmacology of NMDA receptor channel blockers; Implications for therapeutic potential
34. Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?
35. Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients
36. The role of the posterior vermis of monkey cerebellum in smooth-pursuit eye movement control. II. Target velocity-related Purkinje cell activity
37. Glutamate pharmacology and the treatment of schizophrenia; Current status and future directions
38. Smooth pursuit eye movements to extraretinal motion signals; Deficits in motion memory in schizophrenia
39. Smooth pursuit eye movements to extraretinal motion signals; Deficits in relatives of patients with schizophrenia
40. Human smooth pursuit during transient perturbations of predictable and unpredictable target movement
41. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats; Modulation by dopamine
42. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques